Abstract Insulin-like growth factor-I (IGF-I) is an endocrine and autocrine/paracrine growth factor. Recently, we have demonstrated that interrenal aortic coarctation in the rat increases IGF-I mRNA levels in the thoracic aorta, consistent with a role for this mitogen in hypertensive vascular remodeling. The effects of IGF-I are modulated by several IGF binding proteins including IGFBP-3, the main circulating carrier of IGF-I, and IGFBP-4, the main IGF binding protein produced by vascular smooth muscle cells in vitro. To obtain insights into the regulation of IGF-I and more specifically to study potential changes in IGF binding proteins in high-renin hypertension, we studied male Sprague-Dawley rats that had undergone abdominal aortic coarctation. Compared with sham-operated rats, the study rats showed a rapid increase in IGFBP-4 mRNA levels in the hypertensive (thoracic) aorta, reaching a plateau at 3 days (2.5-fold increase) and persisting for at least 14 days. In striking contrast, IGFBP-4 mRNA decreased slightly in the normotensive (abdominal) aorta at 14 days. IGFBP-3 mRNA levels did not change in either vascular bed after coarctation. Study of
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Abstract Insulin-like growth factor-I (IGF-I) is an endocrine and autocrine/paracrine growth factor. Recently, we have demonstrated that interrenal aortic coarctation in the rat increases IGF-I mRNA levels in the thoracic aorta, consistent with a role for this mitogen in hypertensive vascular remodeling. The effects of IGF-I are modulated by several IGF binding proteins including IGFBP-3, the main circulating carrier of IGF-I, and IGFBP-4, the main IGF binding protein produced by vascular smooth muscle cells in vitro. To obtain insights into the regulation of IGF-I and more specifically to study potential changes in IGF binding proteins in high-renin hypertension, we studied male Sprague-Dawley rats that had undergone abdominal aortic coarctation. Compared with sham-operated rats, the study rats showed a rapid increase in IGFBP-4 mRNA levels in the hypertensive (thoracic) aorta, reaching a plateau at 3 days (2.5-fold increase) and persisting for at least 14 days. In striking contrast, IGFBP-4 mRNA decreased slightly in the normotensive (abdominal) aorta at 14 days. IGFBP-3 mRNA levels did not change in either vascular bed after coarctation. Study of I nsulin-like growth factor-I (IGF-I) is a potent mitogen involved in normal growth and development. It exerts its effects through both endocrine and autocrine/paracrine mechanisms. 1 This peptide functions essentially as a progression factor, ie, allowing cells rendered competent by exposure to mitogens such as platelet-derived growth factor (PDGF) to progress through Gi to S phase. 2 We have previously demonstrated IGF-I gene expression in cultured endothelial and vascular smooth muscle cells (VSMCs) 3 ' 4 and have hypothesized that this mitogen may play a key role in the intrinsic growth program in normal and diseased blood vessels. Thus, IGF-I expression is transiently induced in the medial smooth muscle cell layer of rat aorta after balloon angioplasty. 5 Recently, we have shown that in a high-renin model of hypertension in the rat, IGF-I mRNA increases in the hypertensive aorta. 6 This increase may be mediated by both hemodynamic and humoral factors. Thus, angiotensin II transcriptionally regulates IGF-I expression in VSMCs, and IGF-I is required for angiotensin II to exert its mitogenic effects.
hepatic tissue indicated that in coarcted rats IGFBP-4 and IGFBP-3 mRNA levels decreased transiently (approximately 50% at 7 days compared with sham). Circulating IGF-I in coarcted animals decreased slightly (P=.O8), and Western ligand analysis indicated that circulating levels of IGF binding proteins were not altered. Thus, in this high-renin model of hypertension, there is a transient inhibition in hepatic IGFBP-3 and IGFBP-4 mRNA expression, consistent with a humorally mediated effect, and a rapid and sustained rise in IGFBP-4 mRNA in the hypertensive aorta, consistent with a hemodynamically mediated effect. If IGFBP-4 inhibits IGF-I action in vivo (as has been suggested by in vitro data), induction of IGFBP-4 expression in hypertensive blood vessels could serve to limit local vascular growth responses. (Hypertension.
The effects of IGF-I are modulated by a family of specific high-affinity carrier proteins, termed insulin-like growth factor binding proteins (IGFBPs) (reviewed in reference 8). Six IGFBPs have been isolated and their cDNAs cloned. 914 IGFBPs in the pericellular environment have the potential capacity to modulate the local as well as systemic metabolic and mitogenic activities of IGF.
8 ' 15 They have been described to have both inhibitory 16 and/or stimulatory 16 -18 effects. Porcine VSMCs in culture have been shown to secrete IGFBP-4 and IGFBP-2.
19
- 20 Recently, we have demonstrated that rat aortic smooth muscle cells in culture secrete primarily IGFBP-4 and low amounts of IGFBP-3 and a 31-kD IGFBP. 21 The postulated central role of IGFBPs in modulating IGF-I action led us to hypothesize that IGFBPs, like IGF-I, might be regulated in hypertension. The aim of this study was to determine the consequence of the establishment of high-renin hypertension in the rat on IGFBP-4 and IGFBP-3 expression in vascular and extravascular tissues.
Our findings demonstrate a sustained increase in IGFBP-4 mRNA levels in the hypertensive aorta. In marked contrast, abdominal coarctation resulted in a small decrease in IGFBP-4 expression in the abdominal (normotensive) aorta and transiently suppressed IGFBP-4 and IGFBP-3 expression in hepatic tissue. These data indicate that mechanical factors upregulate IGFBP-4 mRNA levels in the vasculature and suggest a unique mechanism whereby induction of this inhibitory binding protein may modulate the final magnitude of the mitogenic response to IGF-I.
Methods

Experimental Animal Model
Abdominal coarctation was carried out as previously described. 6 Male Sprague-Dawley rats (200 to 250 g; Harlan Sprague Dawley Inc, Indianapolis, Ind) were anesthetized with a 1:5 mixture of ketamine and xylazine (20 and 100 mg/kg, respectively). The abdominal aorta was exposed through a left abdominal incision, and the aorta was constricted immediately proximal to the left renal artery with a 4-0 silk suture. The suture was tied around the aorta over a 0.4-mm diameter wire, and the wire was removed. The wound was closed, and all animals received penicillin G as prophylaxis. For sham-operated animals, the aorta was exposed in an identical manner and lifted free from the surrounding tissue proximal to the left renal artery, and a suture was passed around the aorta but not tied. The rats were allowed to recover from anesthesia and were returned to cages for 1, 3, 7, and 14 days. Nonoperated littermates served as control animals at day 0. Animal experimentation was done in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was approved by the Emory Animal Care and Use Committee.
Hemodynamic Studies and Tissue Processing
Baseline blood pressures were obtained by introducing catheters (polyethylene tubing of 0.038-inch outer diameter; Intramedic) into the right carotid and right femoral arteries in a group of control animals (nonoperated) matched for sex, age, and weight. After 1, 3, 7, and 14 days, the operated animals were evaluated in a similar manner after adequate anesthesia. Pressure was recorded with an RM Dynograph type 511 (Beckman Instruments Inc, Bioanalytical Systems Group). The rats were then killed, and tissue was rapidly removed and frozen in liquid nitrogen. The thoracic aorta was excised from the arch to 1 cm above the coarctation. The abdominal aorta was removed from 0.5 cm below the ligature to 0.5 cm distal to its bifurcation.
Northern Analysis
Quantification of IGFBP mRNA transcripts in normotensive and hypertensive rats was carried out by Northern analysis. Four groups of sham-operated and coarcted rats (four rats per group) were used at each time point. RNA was prepared from pooled flash-frozen tissue using the guanidium isothiocyanate/ cesium chloride method. 22 RNA was measured by spectrophotometry, and only RNA with a 260/280 optical density ratio of 1.8 to 2.0 was used. RNA purity was further verified by agarose-formaldehyde gel electrophoresis and ethidium bromide staining. For Northern analysis, 10-p.g samples of total RNA were size-fractionated by agarose-formaldehyde gel electrophoresis before transfer to nylon membranes (GeneScreen Plus, New England Nuclear). RNA loading and transfer efficiencies were verified by methylene blue staining of membranes. Membranes were prehybridized for 3 hours and then hybridized at 42°C in a solution containing 50% formamide, 5X SSPE, 5X Denhardt's solution, 1% sodium dodecyl sulfate (SDS), 10% dextran sulfate (MW 500 000), 100 jig/mL denatured herring sperm DNA, and 5X105 cpm/mL ^-labeled cDNA probe.
The IGFBP-3 and IGFBP-4 cDNAs clones were kindly provided by Dr S. Shimasaki (Whittier Institute for Diabetes and Endocrinology, Scripps Memorial Hospital). Inserts used were the Apa I-BamHI 699-bp restriction fragment of the rat IGFBP-3 RFI-507 clone and the Sma l-Hindlll 444-bp restriction fragment of the rat IGFBP^ RB4-501 clone. The cDNAs were labeled by random priming using [ 32 P]dCTJ J and the Prime-IT II kit from Stratagene. After hybridization, filters were washed with 2x SSPE at room temperature two times, then with 2x SSPE and 2% SDS at 60°C for 30 minutes, then for 15 minutes in 0.1 X SSPE before autoradiography. The film was then scanned by tomodensitometry with a laser densitometer (UltroScan XL, LKB); absorbance curves were integrated and compared. The molecular sizes of the detected RNA species were determined from the migration pattern of a 0.24-to 9.5-kb RNA ladder (GIBCO BRL, Life Technologies, Inc). As an additional control for loading and transfer of RNA samples, filters were cohybridized with a GAPDH cDNA probe. 23 All densitometric data were normalized for the GAPDH signal.
IGF-I Radioimmunoassay and Serum Creatinine Levels
Blood samples from sham-operated and coarcted animals were collected in prechilled tubes and maintained on ice for 2 to 3 hours until coagulation occurred. Serum was collected by centrifugation (1700g, 30 minutes, 4°C). The serum was stored until analysis at -80°C. An acid-ethanol cryoprecipitation method was used to separate IGFBPs. 24 The recovery of 125 I-labeled IGF-I using this method was 46±1% (n=4). Extracted sera were assayed for IGF-I immunoreactivity with a polyclonal anti-IGF-I rabbit antiserum kindly provided by the National Hormone and Pituitary program of the National Institute of Diabetes and Digestive and Kidney Diseases. A double-antibody technique was used to precipitate bound counts using goat anti-rabbit antiserum and normal rabbit serum as a carrier. Standard curves were generated using human recombinant IGF-I (Amgen Biologicals). IGF-I immunoreactivity was expressed as micrograms per liter. Sera from three separate groups of sham-operated and coarcted rats (four rats per group) obtained at 7 and 14 days postoperatively were assayed for creatinine levels. The colorimetric assays were performed with an autoanalyzer by the Division of Animal Resources, Emory University.
Western Ligand Blotting
Sera from sham-operated and coarcted rats were first acidified with an equal volume of 2N acetic acid, incubated at room temperature for 30 minutes, then neutralized by addition of 2N NaOH to obtain a final pH of 6.5 before being mixed with SDS sample buffer and boiled. Western ligand blotting was done according to the method of Hossenlop et al 25 as we have previously described. 21 Briefly, the samples were loaded onto a 4% to 15% gradient SDS-polyacrylamide minigel and electrophoresed for 1 hour at 200 V. For some experiments, 16x20-cm 10% polyacrylamide-SDS gels were used (electrophoresed for 1 hour at 16 mA, then 4 hours at 24 mA). After electrophoresis, proteins were transferred to nitrocellulose, and the membrane was dried and sequentially blocked with 3% Nonidet (NP 40), 1% bovine serum albumin, and 0.1% Tween 20 in Tris-buffered saline before incubation with 4X105 cpm/mL of 123 I-labeled IGF-I for 16 to 18 hours. Rinsed membranes were dried and exposed to film for 1 to 3 days, and band intensity was quantified with an UltroScan XL laser tomodensitometer. Prestained molecular weight markers (BioRad) were used for sizing.
Statistical Analysis
All data represent a minimum of three separate experiments and are expressed as mean±SEM. ANOVA was used for time course analysis, and comparisons between groups were performed with a paired Student's / test when appropriate. dehyde were purchased from Fisher Scientific. All restriction enzymes were from GIBCO BRL, Life Technologies, Inc.
Results
Hemodynamic Measurements
Abdominal interrenal aortic coarctation resulted in a rapid hypertensive response. Fig 1 summarizes mean arterial pressures determined by simultaneous recording of carotid and femoral pressures. Mean carotid arterial pressure in coarcted rats increased by 12±10% at day 1, 28±10% at day 3, and 55±3% at day 14 compared with sham. Femoral arterial pressures decreased acutely after coarctation and then returned gradually toward baseline. At 14 days, femoral pressure in the coarcted animals was similar to carotid pressure in the sham-operated animals. Sham-operated paired littermates had no significant change in blood pressure as measured up to 14 days postoperatively. Carotid and femoral pressures were not significantly different in sham-operated animals, and these pressures did not differ significantly from those of control (nonoperated) animals.
Regulation of Vascular IGFBP-4 and IGFBP-3 mRNA Levels
As indicated in Fig 2, top, Northern analysis of total RNA from rat aorta using an IGFBP-4 cDNA probe yielded the expected 2.3-kb transcript. Compared with sham-operated thoracic aortas, IGFBP-4 mRNA levels increased rapidly in thoracic aortas from banded rats. Fig 2, bottom, shows results from four independent experiments. In each case, the IGFBP-4 mRNA signal obtained from thoracic hypertensive aortas was corrected for the GAPDH signal and compared with IGFBP-4 mRNA levels (corrected for GAPDH) from identical aortic segments from sham-operated rats. The rapid increase in IGFBP-4 mRNA in hypertensive thoracic aortas reached a plateau by 3 days (2.5-fold increase) and persisted for at least 14 days. In striking contrast, aortic constriction did not significantly elevate IGFBP-4 mRNA levels in the abdominal aorta; rather, there was a gradual small decrease compared with sham-operated abdominal aortas. IGFBP-3 mRNA levels did not change significantly in the thoracic or abdominal aorta after aortic constriction (Fig 3) . 
Regulation of Hepatic IGFBP-4 and IGFBP-3 mRNA Levels
To determine the tissue specificity of the observed induction of IGFBP-4 expression in hypertensive aortic segments from coarcted rats, we measured IGFBP-4 and IGFBP-3 mRNA levels in livers from sham-operated and coarcted animals. As shown in Fig 4, top, IGFBP-3 mRNA levels decreased transiently in banded animals, with a maximal decrease at 7 days and a return toward baseline at 14 days. Similarly, hepatic IGFBP-4 mRNA levels decreased transiently in banded animals. The results from four independent experiments are shown in Fig 4, bottom, in which the percent change in hepatic IGFBP-4 and IGFBP-3 mRNA levels (compared with sham-operated rats) is shown. As is evident, aortic coarctation suppressed hepatic IGFBP-3 and IGFBP^t mRNA levels by approximately 50% at day 7 compared with sham-operated rats, and this effect had reversed by 14 days.
Western Ligand Analysis of Circulating IGFBPs
Analysis of rat serum by Western ligand blotting using 125 I-IGF-I detected multiple bands (Fig 5) . A triplet at 40 to 50 kD represents IGFBP-3, which we have confirmed by immunoblotting using anti-human IGBP-3 antiserum (Upstate Biotechnology Inc, results not shown). There is a weak 32-kD band, a stronger 30-kD band consistent with IGFBP-2 as identified by Gargosky et al 26 in rat serum, and a 24-kD IGFBP consistent with IGFBP-4. Densitometric analysis of four independent experiments at 1, 3, 7, and 14 days (results not shown) demonstrated no significant variation in circulating IGFBPs after aortic coarctation.
Serum IGF-I and Creatinine Levels
Measurements of circulating IGF-I (Fig 6) indicated that there was a small decrease in coarcted compared with sham rats that was of borderline statistical significance (P=.O8, n=4). Serum creatinine levels were not significantly different between coarcted or sham-operated animals at 7 days (coarcted, 0.9 ±0.0 mg/dL; sham, 
Discussion
Hypertension is a major risk factor for cardiovascular disease, leading to a substantial rate of morbidity and mortality. 27 Although several peptide growth factors have been postulated to be important in the initiation and progression of vascular growth and remodeling in hypertension, there is little information on the involvement of growth factors in hypertensive VSMC growth in vivo. IGF-I is mitogenic for many cell types and plays a crucial role in mammalian growth. 28 We and others have demonstrated an important role for this peptide in VSMC proliferative responses in vitro.
3 - 47 We have shown an induction of IGF-I transcript levels in the thoracic aorta in abdominally coarcted rats, a high-renin model of hypertension. 6 This increase in IGF-I mRNA is followed by a decrease in IGF-I receptor transcript levels, 29 regulation. We have recently described this phenomenon in VSMCs in vitro. 30 These findings suggest that IGF-I acts as an autocrine factor and participates in VSMC growth responses in this form of hypertension. As IGF-I is complexed to specific high-affinity carrier proteins (IGFBPs), knowledge of the regulation of these carrier proteins is fundamental to our understanding of IGF responsiveness at the cellular level.
We have previously determined that IGFBP-4 mRNA levels vary significantly between proximal and distal aortic segments in the rat (A.A., P.D., unpublished results, 1994). Thus, direct comparisons of IGFBP-4 mRNA levels in thoracic (hypertensive) and abdominal (normotensive) aortas in the coarcted rat are not meaningful. Instead, we compared IGFBP-4 mRNA levels within identical aortic segments from sham-operated and coarcted rats. Our data demonstrate a sustained induction in IGFBP-4 mRNA in the hypertensive aortas of abdominally coarcted animals. This induction of IGFBP-4 is absent in the liver and in a normotensive vascular bed, namely, the abdominal aorta of the coarcted animals. In these aortas, there is a small but significant decrease in IGFBP-4 transcript levels at 14 days. Thus, upregulation of a systemic circulating factor (such as renin) cannot be implicated in the induction of IGFBP-4 in the hypertensive aortas, strongly suggesting that this effect is related to hemodynamic factors, namely, increased blood pressure. Although previous studies have shown that IGFBPs can both stimulate 16 -18 and inhibit 16 the metabolic and mitogenic effects of IGFs, IGFBP-4 has consistently been reported to have inhibitory effects in vitro. 44 We have recently shown that fibroblast growth factor (FGF), another important mitogen for VSMCs, 45 strongly enhances IGFBP-4 release from rat aortic VSMCs. 21 In this regard, it is interesting to note that Cohick et al 20 reported no effect of PDGF, FGF, epidermal growth factor (EGF), and transforming growth factor fi-1 (TGF/3-1) on porcine VSMC IGFBP production. Recently, Chen et al 46 have reported that FGF, TGF-a, and EGF upregulate IGFBP-4 production by rat osteoblast-like cells. Potential upregulation of these growth factors or other cytokines in hypertensive blood vessels of the abdominally coarcted rat could possibly contribute to the observed regulation of IGFBP-4 mRNA.
An intriguing finding in the present study was the transient decrease in hepatic IGFBP-4 and IGFBP-3 mRNA levels in coarcted rats. Although renal failure has been shown to regulate IGFBPs, 8 measurements of serum creatinine levels were not different between sham-operated and coarcted rats, consistent with prior studies demonstrating preserved overall renal function in this model. 47 A potential explanation for the reduction in hepatic IGFBP mRNA levels in coarcted rats is that stimulation of the renin-angiotensin system resulted in inhibition of hepatic IGFBP-4 and IGFBP-3 expression. Indeed, we have previously determined that plasma renin activity increases maximally at 7 days after coarctation and normalizes by 14 days, thus paralleling the change in hepatic IGFBP-4 and IGFBP-3 mRNA levels. 48 Furthermore, recent data from our laboratory indicate that angiotensin II decreases IGFBP-4 mRNA levels and IGFBP-4 and IGFBP-3 secretion from cultured rat aortic smooth muscle cells. 49 It is not likely that the transient decrease in hepatic IGFBP-3 and IGFBP-4 mRNA levels reflected nutritional changes because we have previously shown that aortic coarctation does not alter weight gain in those animals. 6 Although the decrease in hepatic IGFBP mRNA levels in coarcted rats compared with shams was not reflected in changes in circulating IGFBPs, as determined by Western ligand blotting, this method is of limited reliability in quantitating IGFBPs. 50 We have thus not ruled out potential effects of aortic coarctation on the translation of and/or posttranslational modification of IGFBPs nor on changes in the clearance of these proteins. Measurements of circulating IGF-I demonstrated a small decrease after coarctation that was of borderline statistical significance (P=.O8).
Limited data are available on vascular expression of growth factors in animal models of hypertension. Thus, Sarzani et al, 51 using a deoxycorticosterone acetate-salt model of hypertension in the rat, found no induction of PDGF a-chain and /3-chain, FGF, endothelial cell growth factor, IGF-I, and IGF-II but did demonstrate a significant increase in TGF-/3 transcripts in the hypertensive vascular wall. The same group showed an increase in PDGF-/3 receptor mRNA in this model. 32 It is possible that the absence of changes in IGF-I transcript levels in this model was secondary to an inhibitory effect of the mineralocorticosteroid. 53 In the abdominal coarctation model of hypertension, IGF-I mRNA is clearly induced in the hypertensive aorta, as we have previously shown. 6 In summary, our present data indicate that abdominal coarctation in the rat is accompanied by a transient decrease in hepatic IGFBP-4 and IGFBP-3 expression, no change in circulating IGFBPs (as detected by Western ligand blotting), and a rapid and sustained increase in IGFBP-4 mRNA that is restricted to the hypertensive aorta. Further studies, currently underway, are needed to establish correlations between IGFBP-4 mRNA and protein levels in normotensive and hypertensive blood vessels and to characterize the distribution of IGFBP-4 mRNA transcripts in the vasculature. Our current findings support the concept of a local vascular IGF-I system that participates in hypertensive vascular remodeling.
